IPGP Form 4: Director Sale of 1,360 Shares; Weighted Avg $76.24
Rhea-AI Filing Summary
Desmond Jeanmarie F., a director of IPG Photonics Corporation (IPGP), reported the sale of 1,360 shares of the issuer's common stock on 08/08/2025. The filing states the transactions were sales at prices ranging from $76.02 to $76.51 per share with a weighted average price of $76.24. After the reported sale, the reporting person beneficially owned 9,740 shares. The form is signed on behalf of the reporting person by attorney-in-fact Adam N. King on 08/08/2025. The filer lists an address at C/O IPG Photonics Corporation, 377 Simarano Drive, Marlborough, MA 01752. The filer offers to provide, upon request, the breakdown of shares sold at each separate price.
Positive
- None.
Negative
- None.
Insights
TL;DR Director sale of 1,360 IPGP shares disclosed; weighted average price $76.24; remaining beneficial ownership reported at 9,740 shares.
The Form 4 transparently records an open-market sale executed on 08/08/2025. The filing lists the sale quantity, the range of prices ($76.02–$76.51) and a weighted average price ($76.24), and discloses the post-transaction beneficial holding (9,740 shares). The document does not state the percentage of outstanding shares this position represents or the reason for the sale, and the filer notes they can provide the per-price breakdown upon request. Based solely on the filing, this is a routine insider sale disclosure without additional context to assess materiality.
TL;DR A director-authorized sale was reported and the Form 4 is signed by an attorney-in-fact; the filing does not indicate a trading plan.
The reporting person is identified as a Director and the Form 4 was executed by an attorney-in-fact, Adam N. King, on 08/08/2025, which is properly disclosed. The form contains the standard notice about Rule 10b5-1 plans but does not indicate that the transaction was made pursuant to such a plan. The filing also offers to supply a detailed per-price breakdown on request. From a governance perspective, the disclosure meets Section 16 reporting requirements but lacks contextual details (e.g., relation to company policies or trading plans) within the document itself.
FAQ
Who filed the Form 4 for IPG Photonics (IPGP)?
What transaction was reported on the IPGP Form 4 dated 08/08/2025?
At what prices were the IPGP shares sold?
How many IPGP shares did the reporting person own after the sale?
Was the transaction executed under a 10b5-1 trading plan?
Who signed the Form 4 and when?